POAI subsidiary announces new media for growing ovarian tumors in lab Using new product, TumorGenesis partners have identified 25 cell types from ovarian cancers New media available as cell-culture market expected to reach $2.3 billion by 2024 Predictive Oncology Inc. (NASDAQ: POAI), a leader in the cancer precision-medicine field, along with its subsidiary TumorGenesis Inc., […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.